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Since superior vena cava syndrome (SVCS) is a critical condition, immediate diagnostic approach and
therapy are imperative to avoid potentially life-threatening complications. Here, we report a case of lung
cancer with SVCS, which was diagnosed through intravascular tumor biopsy using endobronchial
ultrasound-guided transbronchial needle aspiration (EBUS-TBNA). EBUS-TBNA enabled us to obtain tis-
sue sufﬁcient for diagnosis, without signiﬁcant complications. Prompt diagnosis was followed by
appropriate anticancer treatment and improvement in the symptoms. For patients suspected of SVCS and
requiring prompt pathologic diagnosis, we can consider EBUS-TBNA to diagnose intravascular or medi-
astinal tumors and provide an accurate diagnosis.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).The superior vena cava syndrome (SVCS) is a critical condition,
which encompasses symptoms and signs caused by obstruction of
the superior vena cava (SVC) [1]. The blockage of blood ﬂow in the
SVC results in edema of head and upper body, which leads to
functional compromise of the larynx or pharynx and cerebral
edema, manifested as headache, confusion, and coma [2].
Furthermore, decreased venous return may cause hemodynamic
compromise [1]. Immediate diagnostic approach and emergency
therapy are imperative to avoid potentially life-threatening com-
plications [3].
Most common cause of SVCS is intrathoracic malignancy such as
lung cancer, lymphoma and metastatic cancer [4]. Since treatment
varies according to the histology of the underlying disease, accurate
histologic diagnosis is crucial in patients with SVCS [2]. To obtain
tissue diagnosis, invasive procedures such as mediastinoscopy and
mediastinotomy may be required. Previous studies indicated pa-
tients with SVCS compared to those without SVCS show signiﬁ-
cantly higher rate of complications from mediastinal procedures
[5]. Recently, endobronchial ultrasound-guided transbronchialand Critical Care Medicine,
, Sungkyunkwan University
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).
Ltd. This is an open access article uneedle aspiration (EBUS-TBNA) has been performed in patients
presented with SVCS. Recent reports suggest EBUS-TBNA has high
diagnostic accuracy and is relatively safe for the diagnosis of SVCS
[6].
EBUS-TBNA is a minimally invasive procedure that was devel-
oped for evaluating mediastinal lymph nodes with real-time visu-
alization of intrathoracic structures [7]. EBUS-TBNA has a key role in
diagnosis of lung cancer and mediastinal staging by sampling
metastatic lymph nodes currently [8]. In addition, Park et al. re-
ported case describing intravascular mass diagnosed as pulmonary
angiosarcoma using EBUS-TBNA biopsy [9]. However, there is
limited information on its role in diagnosing intravascular lesions.
Herein, we report a case of lung cancer invading SVC, which was
diagnosed by biopsy of intravascular mass using EBUS-TBNA.
1. Case report
A 46-year-old man was transferred to our emergency room for
facial and upper trunk swelling and dyspnea with chest discomfort
that had begun 1 month earlier. He was a 30-pack-year current
smoker. On physical examination, neck vein engorgement was
observed, with distended veins and edema on the upper trunk and
both arms. Chest radiograph showed consolidation in the right
paratracheal area that suggestive of central malignancy (Fig. 1). We
performed chest computed tomography (CT) with contrastnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Chest radiograph shows consolidative mass in the right mediastinal area (ar-
row) and left pleural effusion.
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tissue mass in the right paratracheal area that has invaded into
the SVC and extended to the right atrium with bilateral pleural
effusions (Fig. 2AeC). Positron emission tomography (PET)-CT with
18F-ﬂuorodeoxyglucose (FDG) showed increased FDG uptake, with
a maximum standardized uptake value (SUVmax) of 10.6 in the SVC
(Fig. 2D). It was not available to obtain tissue from the primary
lesion in the right upper lung using CT-guided percutaneous core
needle aspiration (PCNA). In the bronchoscopy, there was noFig. 2. Chest computed tomography (CT) scan shows 38 mm primary lung mass invading th
atrium (B). Transverse lung window CT image shows the mass fully occupying the SVC (C)endobronchial lesion. Therefore, we decided to perform EBUS-
TBNA to obtain tissue from the intravascular mass in SVC. EBUS-
TBNA was performed using an ultrasound bronchoscope with a
linear scanning transducer. Under ultrasound visualization, the SVC
was tightly packed by the mass and blood streamwas not detected
around the tumor. The tumor was punctured using a 22-gauge
needle under real-time visualization (Fig. 3A). During the proced-
ure, there was no serious bleeding or other complication. Cytopa-
thology conﬁrmed poorly differentiated adenocarcinoma, with
TTF-1-positive immunohistochemistry (Fig. 3B). There were no
epidermal growth factor receptor (EGFR) gene mutations or KRAS
gene mutations. He received 4 cycles of gemcitabine-carboplatin
chemotherapy for the treatment of lung cancer. Two months after
the chemotherapy, chest CT showed that the tumor size was
decreased and his symptoms were relieved as well (Fig. 4).2. Discussion
In patients with newly diagnosed malignancy presenting with
SVCS, urgent diagnostic evaluation and treatment to alleviate
symptoms are required to avoid serious complications. We are
reporting a case of lung cancer with SVCS diagnosed through
intravascular tumor biopsy using EBUS-TBNA. Fortunately, since
diagnosis was conﬁrmed pathologically, the patient underwent
anticancer treatment and his symptoms were improved.
In SVCS, timely establishment of the underlying diagnosis of
SVCS is imperative for starting appropriate treatment. Surgical
procedures including mediastinoscopy and mediastinotomy may
be required. General anesthesia itself in patients with SVCS is
related to high morbidity and mortality [10]. Also, patients with
SVCS underwent mediastinoscopy and mediastinotomy fore right mediastinum (arrow) (A). On coronal image, SVC mass is extended to the right
. PET-CT images shows FDG uptake with SUVmax of 10.6 on the SVC mass (D).
Fig. 3. Endobronchial ultrasound imaging and pathology specimens from EBUS-TBNA. Ultrasound imaging shows the mass within SVC wall (arrows) (A). The biopsy shows poorly
differentiated adenocarcinoma (H&E, 400) (B).
Fig. 4. Initial lung mass in chest CT scan (A), and follow up chest CT shows interval decrease in size of the primary lung cancer (B).
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associated with major hemorrhage, airway obstruction, wound
infection, etc. [5] In our case, EBUS-TBNA enabled us to obtain tissue
via the SVC immediately without signiﬁcant complications, avoid-
ing an undesirable thoracotomy under general anesthesia.
As in this case, Jeong et al. previously described a critically ill
patient who was diagnosed by using EBUS-TBNA [11]. The patient
with extensive pretreated lung cancer causing respiratory failure
conﬁrmed pathologic diagnosis using EBUS-TBNA. Both cases sug-
gest that physicians necessitate new perspective on the use of
EBUS-TBNA in critically ill patients. EBUS-TBNA, which is a novel
diagnostic modality and relatively safe technique with high diag-
nostic accuracy, may be alternative diagnostic method for critically
ill patients who cannot undergo surgery under general anesthesia.
Several cases about EBUS-TBNA of intravascular lesions have
been reported. Harris et al. reviewed 10 reported cases of EBUS-
TBNA guided biopsy for diagnosis of intravascular masses, and
there are no signiﬁcant complications [12]. Similarly, Von Bartheld
et al. reported a case series that demonstrated the safety of trans-
aortic ﬁne needle aspiration under real-time endoscopic ultra-
sound guidance in the diagnosis of lung tumors and lymph nodes
[13]. In the report, only two of 12 patients had a possible para-
aortic hematoma on the EUS image after the biopsy, and they
recovered uneventfully. Also, Panchabhai et al. revealed safety of
transvascular approach of EBUS-TBNA. No complications were
noted in any of the 10 cases [14]. Likewise, our patient was suc-
cessfully diagnosed using EBUS-TBNA to puncture the SVC withoutany complications. Considering the reports and our case, in expe-
rienced hands, the intravascular and transvascular approach using
EBUS-TBNA may be safe procedure.
In conclusion, our case showed the safety and feasibility of using
EBUS-TBNA to diagnose fully packing SVC masses. It suggests that
when the patient who suspected SVCS and needs prompt patho-
logic diagnosis, we can consider EBUS-TBNA for diagnosing intra-
vascular or mediastinal tumors and providing exact diagnosis to
clinicians. It can also provide sufﬁcient tissue as much as surgical
biopsy for immunohistochemistry and EGFR/KRAS mutation ana-
lyses for targeted therapy.
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